308 related articles for article (PubMed ID: 33509004)
1. Cubogel as potential platform for glaucoma management.
Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM
Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004
[TBL] [Abstract][Full Text] [Related]
2. Effect of Formulation Variables and Gamma Sterilization on Transcorneal Permeation and Stability of Proniosomal Gels as Ocular Platforms for Antiglaucomal Drug.
Sayed S; Abdelmoteleb M; Amin MM; Khowessah OM
AAPS PharmSciTech; 2020 Feb; 21(3):87. PubMed ID: 32016607
[TBL] [Abstract][Full Text] [Related]
3. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
[TBL] [Abstract][Full Text] [Related]
4. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
[TBL] [Abstract][Full Text] [Related]
5. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
Dubey V; Mohan P; Dangi JS; Kesavan K
Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
[TBL] [Abstract][Full Text] [Related]
6. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
Sharma PK; Chauhan MK
Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
[No Abstract] [Full Text] [Related]
7. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
Kouchak M; Mahmoodzadeh M; Farrahi F
AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
[TBL] [Abstract][Full Text] [Related]
8. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
Soni PK; Saini TR
Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
[TBL] [Abstract][Full Text] [Related]
9. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures.
Afify EAMR; Elsayed I; Gad MK; Mohamed MI; Afify AEMR
PLoS One; 2018; 13(2):e0191415. PubMed ID: 29401498
[TBL] [Abstract][Full Text] [Related]
11. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
12. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
14. Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation.
Sayed S; Habib BA; Elsayed GM
J Liposome Res; 2018 Sep; 28(3):182-192. PubMed ID: 28480807
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.
Ahirrao M; Shrotriya S
Drug Dev Ind Pharm; 2017 Oct; 43(10):1686-1693. PubMed ID: 28574732
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization,
Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA
Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.
Naguib MJ; Elsayed I; Teaima MH
Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861
[TBL] [Abstract][Full Text] [Related]
18. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
[TBL] [Abstract][Full Text] [Related]
19. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
20. Novel cubosome based system for ocular delivery of acetazolamide.
Teba HE; Khalil IA; El Sorogy HM
Drug Deliv; 2021 Dec; 28(1):2177-2186. PubMed ID: 34662264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]